The Data and Safety Monitoring System at the University of Texas Southwestern Medical Center (UTSW) Simmons Cancer Center is designed to ensure patient safety and data quality for cancer-related clinical trials. The Data and Safety Monitoring Committee (DSMC) is an independent committee appointed by the Deputy Director of the Cancer Center and is responsible for carrying out the data and safety monitoring plan for the Cancer Center. The DSMC can recommend trial modification, suspension, or closure based on safety or regulatory concerns. Recommendations for trial suspension or closure are implemented through the Deputy Director of the Cancer Center and the IRB. The essential functions of the DSMC include: * Review and tracking of all SAE's reported for cancer-related trials. * Full committee review of selected adverse events. * Annual systematic review of all institutional therapeutic trials. * Independent evaluation of treatment responses. * Investigation of potential regulatory compliance violations. * Weekly monitoring of toxicities and systematic review of all first accruals to Phase I trials. * Comprehensive documentation auditing for 10% of all cancer-related clinical trials. * Serves as the DSMC for any therapeutic trial lacking a DSMC. The DSMC membership consists of a Chairperson and Co-Chairperson, and representation from biostatistics, nursing, regulatory, pharmacy, and faculty. Faculty members are selected from all the oncology treatment modalities (Surgery, Radiation Oncology and Medical Oncology). A DSMC Coordinator provides administrative support for all of the DSMC activities and a Quality Assurance &Education Coordinator conducts the internal audits.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA142543-04
Application #
8519971
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
4
Fiscal Year
2013
Total Cost
$54,450
Indirect Cost
$27,466
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Singal, Amit G; Tiro, Jasmin A; Murphy, Caitlin C et al. (2018) Mailed Outreach Invitations Significantly Improve HCC Surveillance Rates in Patients With Cirrhosis: A Randomized Clinical Trial. Hepatology :
Ludlow, Andrew T; Wong, Mandy Sze; Robin, Jerome D et al. (2018) NOVA1 regulates hTERT splicing and cell growth in non-small cell lung cancer. Nat Commun 9:3112
Lewis, Joshua E; Costantini, Francesco; Mims, Jade et al. (2018) Genome-Scale Modeling of NADPH-Driven ?-Lapachone Sensitization in Head and Neck Squamous Cell Carcinoma. Antioxid Redox Signal 29:937-952
Rinkenberger, Nicholas; Schoggins, John W (2018) Mucolipin-2 Cation Channel Increases Trafficking Efficiency of Endocytosed Viruses. MBio 9:
Li, Xiangyi; Baek, GuemHee; Ramanand, Susmita G et al. (2018) BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer. Cell Rep 22:796-808
Balasubramanian, Bijal A; Jetelina, Katelyn K; Bowen, Michael et al. (2018) Surveillance for colorectal cancer survivors in an integrated safety-net health system in the United States. Int J Care Coord 21:26-35
Li, Ran; Chiguru, Srinivas; Li, Li et al. (2018) Targeting Phosphatidylserine with Calcium-Dependent Protein-Drug Conjugates for the Treatment of Cancer. Mol Cancer Ther 17:169-182
Wijayatunge, Ranjula; Holmstrom, Sam R; Foley, Samantha B et al. (2018) Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis. Mol Cell Biol 38:
Rashdan, Sawsan; Minna, John D; Gerber, David E (2018) Diagnosis and management of pulmonary toxicity associated with cancer immunotherapy. Lancet Respir Med 6:472-478
Miyata, Naoteru; Morris, Lindsey L; Chen, Qing et al. (2018) Microbial Sensing by Intestinal Myeloid Cells Controls Carcinogenesis and Epithelial Differentiation. Cell Rep 24:2342-2355

Showing the most recent 10 out of 501 publications